» Articles » PMID: 7157414

Inhibition of Mitochondrial Aldehyde Dehydrogenase by Malondialdehyde

Overview
Journal Toxicol Lett
Publisher Elsevier
Specialty Toxicology
Date 1982 Nov 1
PMID 7157414
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Rat liver mitochondria contain an aldehyde dehydrogenase (ALDH, EC 1.2.1.3) with a low Km for acetaldehyde (2 microM) which is susceptible to inhibition by a variety of agents including p-chloromercuribenzoate and arsenite. This low Km ALDH isozyme has been shown to be decreased in activity following CCl4 treatment in vivo and by lipid peroxidation in vitro. Malondialdehyde, the most studied product of lipid peroxidation, was investigated for possible inhibitory effects on the low Km ALDH for rat liver mitochondria. Malondialdehyde was found to be a potent inhibitor of the enzyme. The enzyme was equally sensitive to inhibition when intact mitochondrial preparations were compared with disrupted mitochondria. The extent of enzyme inhibition was dependent on malondialdehyde concentration and time of incubation. High concentrations of malondialdehyde completely inhibited low Km mitochondrial ALDH activity. Malondialdehyde was found to inhibit the low Km ALDH irreversibly. The rate of ALDH inactivation exhibited two phases, one a rapid rate phase (5-15 s) and a second slower rate phase, both of which showed rates which were dependent on malondialdehyde concentration. These data show that malondialdehyde is a potent, high affinity, irreversible inhibitor of the low Km ALDH of rat liver mitochondria. This ALDH isozyme is considered to be the most important enzyme in acetaldehyde metabolism. Malondialdehyde inhibition of the low Km ALDH may be important since both ethanol and acetaldehyde are thought to stimulate hepatic lipid peroxidation.

Citing Articles

Neuroprotective Effects of Aldehyde-Reducing Composition in an LPS-Induced Neuroinflammation Model of Parkinson's Disease.

Kang S, Noh Y, Oh S, Yoon H, Im S, Kwon H Molecules. 2023; 28(24).

PMID: 38138478 PMC: 10745824. DOI: 10.3390/molecules28247988.


Aldehyde dehydrogenase 7A1 (ALDH7A1) attenuates reactive aldehyde and oxidative stress induced cytotoxicity.

Brocker C, Cantore M, Failli P, Vasiliou V Chem Biol Interact. 2011; 191(1-3):269-77.

PMID: 21338592 PMC: 3387551. DOI: 10.1016/j.cbi.2011.02.016.


Regulation of human mitochondrial aldehyde dehydrogenase (ALDH-2) activity by electrophiles in vitro.

Oelze M, Knorr M, Schell R, Kamuf J, Pautz A, Art J J Biol Chem. 2011; 286(11):8893-900.

PMID: 21252222 PMC: 3058968. DOI: 10.1074/jbc.M110.190017.


Dopamine-derived biological reactive intermediates and protein modifications: Implications for Parkinson's disease.

Jinsmaa Y, Florang V, Rees J, Mexas L, Eckert L, Allen E Chem Biol Interact. 2011; 192(1-2):118-21.

PMID: 21238438 PMC: 3109112. DOI: 10.1016/j.cbi.2011.01.006.


Products of oxidative stress inhibit aldehyde oxidation and reduction pathways in dopamine catabolism yielding elevated levels of a reactive intermediate.

Jinsmaa Y, Florang V, Rees J, Anderson D, Strack S, Doorn J Chem Res Toxicol. 2009; 22(5):835-41.

PMID: 19388687 PMC: 2696154. DOI: 10.1021/tx800405v.